ASBP
Aspire Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.87
−4.11%Margins
Gross margin
18.3%
EBITDA margin
3367.4%
EBIT margin
-7259.9%
Net margin
—
FCF margin
-7358.2%
-94.0%
Return on equity
-81.6%
Return on assets
-60.3%
Return on invested capital
0.01x
Asset turnover
-$7.2M
Cash from operations
$8.67
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026